Tonix Pharmaceuticals Holding Corp.

TNXP · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$130-$117-$110-$92
Dep. & Amort.$3$4$1$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$5$9$11$8
Change in WC$6-$0-$0$6
Other Non-Cash$55$1$0$3
Operating Cash Flow-$61-$102-$98-$76
Investing Activities
PP&E Inv.-$0-$8-$48-$35
Net Acquisitions$0-$22$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$1$0$0
Investing Cash Flow-$0-$29-$48-$35
Financing Activities
Debt Repay.-$2$9$0$0
Stock Issued$140$19$94$212
Stock Repurch.$0-$14$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$3$23-$7$0
Financing Cash Flow$135$37$88$212
Forex Effect$0-$0-$0-$0
Net Chg. in Cash$74-$95-$58$102
Supplemental Information
Beg. Cash$26$120$179$77
End Cash$100$26$120$179
Free Cash Flow-$61-$110-$146-$111